Article

Integrating the Secretome and Interactome to Identify Novel Biomarkers and Therapeutic Targets in Colorectal Cancer

2025-04-24

Abstract excerpt

<title>Abstract</title> <p>Background Cancer is extensively studied, yet its origins and progression remain unclear. A key question is why tumors of the same type vary in aggressiveness and treatment response. In colorectal cancer (CRC), the third most common cancer, this variability led to the identification of molecular subtypes (CMS). However, the tumor microenvironment remains poorly understood and may be cr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 78f87319-9587-565c-bb6d-4b6f226ec19b
DOI: 10.21203/rs.3.rs-6314164/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating the Secretome and Interactome to Identify Novel Biomarkers and Therapeutic Targets in Colorectal CancerDOI 10.21203/rs.3.rs-6314164/v1Read

A Comprehensive Multi-Omics Analysis Identifies a Robust Scoring System for Cancer-Associated Fibroblasts and Intervention Targets in Colorectal CancerSemantic proximity Read

Cellular Ligand-Receptor Perturbations Unravel MEIS2 as a Key Factor for the Aggressive Progression and Prognosis in Stage II/III Colorectal Cancer.Semantic proximity Read

Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.Semantic proximity Read

Molecular pathological classification of colorectal cancer—an updateSemantic proximity Read

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitorsSemantic proximity Read

Redefining colorectal cancer classification and clinical stratification through a single-cell atlasSemantic proximity Read

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancerSemantic proximity Read

Mixed data analysis detected Endocrine Fibroblast Growth Factors (FGF19, FGF21, and FGF23) as Prognostic and Diagnostic Markers of Colorectal Neoplasia and CarcinomaSemantic proximity Read

CMS4-focused multi-omic integration enhances antigen target identification in colorectal cancerSemantic proximity Read

Exploring the prognostic value of N4-acetylcytosine- modified genes in colorectal cancer using transcriptomics combined with single-cell dataSemantic proximity Read

A novel prognostic model for colorectal cancer based on epithelial cell marker genes identified and validated by combining Single-Cell and Bulk RNA- SequencingSemantic proximity Read

Single-cell and spatial transcriptomic analysis reveals tumor cell heterogeneity and underlying molecular program in colorectal cancerSemantic proximity Read